These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11731625)

  • 1. Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
    Cooper A; Yusuf H; Rodewald L; Malik T; Pollard R; Pickering L
    Pediatrics; 2001 Dec; 108(6):E98. PubMed ID: 11731625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B immunisation coverage of infants born to chronic carrier mothers in Victoria.
    Oman KM; Carnie J; Ruff T
    Aust N Z J Public Health; 1997 Dec; 21(7):731-4. PubMed ID: 9489190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.
    ;
    Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28847980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
    Vié le Sage F; Gaudelus J; Lert F; Dufour V; Texier N; Pouriel M; Schück S; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):185-94. PubMed ID: 27238163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time.
    Freed GL; Bordley WC; Clark SJ; Konrad TR
    Pediatrics; 1994 May; 93(5):747-51. PubMed ID: 8165072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
    Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series.
    Yusuf HR; Daniels D; Smith P; Coronado V; Rodewald L
    JAMA; 2000 Aug 23-30; 284(8):978-83. PubMed ID: 10944643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of universal hepatitis B immunization practices of Illinois pediatricians.
    Kraus DM; Campbell MM; Marcinak JF
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):936-42. PubMed ID: 8075737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):203-4. PubMed ID: 12653460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal hepatitis B immunization.
    Kim SC; Sinai LN; Casey R; Pinto-Martin JA
    Pediatrics; 1995 May; 95(5):764-6. PubMed ID: 7724320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination.
    Anderson S; Harper LM; Dionne-Odom J; Halle-Ekane G; Tita ATN
    Int J Gynaecol Obstet; 2018 Apr; 141(1):126-132. PubMed ID: 29315536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
    Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.